Sunitinib has shown efficacy in a phase II study of pancreatic neuroendocrine tumor patients.
Filed under: kinase | Tagged: kinase, multikinase, Pfizer, SU-11248, SU11248, sunitinib, sutent | Comments Off
Merck KGaA (Merck-Serono) has initiated a Phase III study of Erbitux in combination with Xeloda and Cisplatin for the treatment of gastric tumors.
Filed under: Uncategorized | Tagged: BMS, cetuximab, erbitux, HER1, ImClone, Merck KGaA, Merck-Serono | Comments Off